Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering

The Quick Take
BOSTON, Oct. 29, 2026 /PRNewswire/ -- Bambusa Therapeutics, Inc. (Nasdaq: BBTX) ("Bambusa Therapeutics" or "Bambusa"), a clinical-stage biopharmaceutical company developing next-generation, long-acting precision bispecific antibodies for immunology and inflammation, today announced the...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
SKE Brings Halloween Spirit to IRONWORKS London's Electronic Music Scene
LONDON, Oct. 29, 2026 /PRNewswire/ -- SKE has partnered with IRONWORKS London as the official exclusive sponsor of the vape category for the venue's first…
Business
Hanwha Investment & Securities and Chainlink Form Strategic Partnership to Tokenize, Connect, and Collateralize Real-World Assets Worldwide
Hanwha Investment & Securities adopts the Chainlink data standard and CCIP as the official oracle infrastructure powering its global RWA tokenization platform…
Business
Resonant Clinical Solutions stellt eine Reihe von Asset-Management-Programmen vor, die Informationen und Unterstützung für Strategien zur Probenlagerung in klinischen Studien bieten
Der führende Lösungsanbieter bringt Programme für ferngesteuertes, proaktives und strategisches Asset-Management auf den Markt, die darauf ausgelegt sind, den…
Business
